Blackrock Health Sciences Trust Stock Forecast

Buy candidate since Jun 22, 2026 Gain 2.13%

The Blackrock Health Sciences Trust stock price gained 1.02% on the last trading day (Wednesday, 24th Jun 2026), rising from $40.31 to $40.72. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.14% from a day low at $39.99 to a day high of $40.84. The price has been going up and down for this period, and there has been a 0.59% gain for the last 2 weeks. Volume fell on the last day by -4 thousand shares and in total, 34 thousand shares were bought and sold for approximately $1.40 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.86% during the next 3 months and, with a 90% probability hold a price between $40.67 and $42.87 at the end of this 3-month period.

BME Signals & Forecast

The Blackrock Health Sciences Trust stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $40.18 and $39.73. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 2.31%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. The stock had a Golden Star Signal on Thursday, May 21, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Blackrock Health Sciences Trust stock

Blackrock Health Sciences Trust finds support from accumulated volume at $39.61 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.85 between high and low, or 2.14%. For the last week the stock has had daily average volatility of 1.47%

Our recommended stop-loss: $38.95 (-4.35%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 3 days ago.)

Trading Expectations (BME) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Blackrock Health Sciences Trust to open at $40.52, and during the day (based on 14 day Average True Range), to move between $40.42 and $41.02, which gives a possible trading interval of +/-$0.609 (+/-1.51%) up or down from last closing price. If Blackrock Health Sciences Trust takes out the full calculated possible swing range there will be an estimated 1.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $40.89 (0.42%) than the support at $39.61 (2.73%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Blackrock Health Sciences Trust stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Blackrock Health Sciences Trust stock to perform well in the short-term.

Current score: 3.003 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 25, 2026 - $40.52 ( 0.496%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk